U.S.: FDA panel: We’re OK if dangerous drug Avandia stays on the market
- 20
FDA panel members voted to allow Avandia’s sale; most wanted to restrict it - 12 members of the panel voted to take it off the market
- one person abstained from the vote for some stupid reason source